![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » BioForm Responds to Artes Medical Patent Suit
BioForm Responds to Artes Medical Patent Suit
April 28, 2005
BioForm Medical has responded to the August 2004 patent infringement suit by Artes Medical. BioForm believes the patent infringement suit by Artes is without merit, and BioForm has responded with defenses based on: 1) a breach of contract by one of Artes' founders in the purported transfer of the patent to Artes; 2) the fact that the patent in dispute is not valid and is unenforceable due to false statements of inventorship; and 3) that the claims in this patent do not cover BioForm's products. BioForm has also countersued for damages and equitable relief.
PharmaLive (http://www.medadnews.com/News/Index.cfm?articleid=233668)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct